Vyvanse and Chronic kidney disease - a phase IV clinical study of FDA data
Summary:
Chronic kidney disease is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Nexium, and have Gastroesophageal reflux disease.
The phase IV clinical study analyzes which people have Chronic kidney disease when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,872 Vyvanse users. Check the latest studies of Vyvanse.
What is Chronic kidney disease?
Chronic kidney disease is found to be associated with 1,830 drugs and 1,371 conditions by eHealthMe. Check the latest studies of Chronic kidney disease.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 72 people (0.26%) have Chronic kidney disease.

Among these 72 people:
How long have people been on Vyvanse when they have Chronic kidney disease? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 20 %
- 2 - 5 years: 80 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Chronic kidney disease when taking Vyvanse? *
- female: 50 %
- male: 50 %
What is the age of people who have Chronic kidney disease when taking Vyvanse? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 28.79 %
- 40-49: 25.76 %
- 50-59: 36.36 %
- 60+: 9.09 %
What are other drugs people take besides Vyvanse? *
- Nexium: 38 people, 52.78%
- Prilosec: 28 people, 38.89%
- Nexium 24hr: 25 people, 34.72%
- Protonix: 23 people, 31.94%
- Promethazine: 23 people, 31.94%
- Prilosec Otc: 21 people, 29.17%
- Proair Hfa: 18 people, 25.00%
- Prevacid: 17 people, 23.61%
- Abilify: 17 people, 23.61%
- Ondansetron: 16 people, 22.22%
What are other side effects people have besides Chronic kidney disease? *
- Acute Kidney Failure: 32 people, 44.44%
- Stress And Anxiety: 19 people, 26.39%
- Pain: 18 people, 25.00%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 16 people, 22.22%
- Emotional Distress: 16 people, 22.22%
- Interstitial Nephritis (inflammation of the kidney): 11 people, 15.28%
- Renal Injury (kidney injury): 10 people, 13.89%
- Osteoporosis (bones weak and more likely to break): 10 people, 13.89%
- Bone Density Decreased: 10 people, 13.89%
- Nephrogenic Anaemia (anaemia due to kidney disease): 10 people, 13.89%
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 41 people, 56.94%
- Pain: 31 people, 43.06%
- Infection: 18 people, 25.00%
- High Blood Pressure: 18 people, 25.00%
- Stress And Anxiety: 16 people, 22.22%
- Hiv Infection: 16 people, 22.22%
- Inflammation: 13 people, 18.06%
- Hypersensitivity: 13 people, 18.06%
- High Blood Cholesterol: 11 people, 15.28%
- Nausea (feeling of having an urge to vomit): 10 people, 13.89%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Chronic kidney disease?
- Check whether Chronic kidney disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,872 reports)
Chronic kidney disease treatments and more:
- Chronic kidney disease (145,469 reports)
How severe was Chronic kidney disease and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chronic kidney disease:
- Chronic kidney disease (1,830 drugs)
Browse all the conditions that are associated with Chronic kidney disease:
- Chronic kidney disease (1,371 conditions)
Related publications that referenced our studies
- Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Melphalan Hydrochloride cause Gastrointestinal Haemorrhage? - now
- Could Provera cause Movement - Uncoordinated? - 7 seconds ago
- Could Provera cause Drug Hypersensitivity? - 8 seconds ago
- Could Rivastigmine cause Aggression? - 10 seconds ago
- Could Seroquel cause Antipsychotic Drug Level Increased? - 11 seconds ago
- Could Tacrolimus cause Hepatitis B Surface Antigen Positive? - 14 seconds ago
- Drug interactions of Enoxaparin Sodium and Azacitidine - 15 seconds ago
- Bipolar Disorder and Birth Control - 17 seconds ago
- Could Melatonin cause Face Injury? - 21 seconds ago
- Biliary Cirrhosis Primary and Hepatic Encephalopathy - 22 seconds ago